相关实验视频

Updated: May 12, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

分子与抗体相遇:下一代抗体-药物结合物

Yiran Tao¹, Ying Lu¹, Bin Yu²

¹Department of Pulmonary and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.

Trends in pharmacological sciences

|May 9, 2025

概括

分子-抗体结合物 (MAC) 通过使用分子作为有效载荷,为癌症治疗提供了一种新的方法. 与传统的抗体-药物合物 (ADC) 相比,这些合物有望提高疗效和减少副作用.

科学领域:

在瘤学瘤学.
药物发现药物发现药物发现
分子药理学分子药理学

背景情况:

抗体-药物结合物 (ADC) 通过将细胞毒剂直接输送到瘤细胞,从而改变了癌症治疗.
对ADC有效载荷多样性的限制和药物耐药性的增加需要新的治疗策略.
以其催化活性而闻名的分子,为向药物输送提供了一条新的途径.

研究的目的:

引入和审查分子-抗体结合物 (MAC) 作为瘤学中的创新有效载荷模式.
探索MACs的机制,进展和治疗潜力.
为了将MAC与传统的ADC和独立的分子合剂进行比较.

主要方法:

关于分子,ADC和新兴MAC技术的现有文献的审查.
在抗体结合的背景下分析分子的催化和事件驱动机制.
对目前正在开发中的MAC的临床前和临床数据的检查.

主要成果:

马克利用分子的独特特性,以提高目标交付和有效性.
马克显示出潜在的减少目标外毒性和改善的治疗指数.
目前有两种MAC候选药物正在进行临床试验,表明有前途的治疗潜力.

结论:

在传统的ADC之外,MACs代表了显著的进步,为癌症治疗提供了更强大,更有针对性的方法.
分子的催化性质为克服耐药性和提高治疗结果提供了明显的优势.
进一步的研究和开发对于应对挑战和充分实现临床瘤学中MAC的潜力至关重要.

关键词:

抗体药物合物抗体药物合物人工智能的人工智能是人工智能.分子粘合剂分子粘合剂分子粘抗体结合物结合物有针对性的蛋白质降解降解.

更多相关视频

Antibody Labeling with Fluorescent Dyes Using Magnetic Protein A and Protein G Beads

Antibody Labeling with Fluorescent Dyes Using Magnetic Protein A and Protein G Beads

Published on: September 15, 2016

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...